Heart Failure
Research demonstrates ability of MYO-VAD to prevent progression of heart disease
Published in Medical Devices and Surgical Technology Week, October 15th, 2006
The finding was featured in a paper presented at a recent ASAIO (American Society for Artificial Internal Organs) conference by Mark A. Anstadt, M.D., FACS, associate professor of Cardiothoracic Surgery at Wright State University, and colleagues. Anstadt is chairman of the scientific advisory board for Myotech, the company developing the MYO-VAD. Biophan Technologies, Inc. holds a 42% interest in Myotech, with rights...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Adrenocortical Cancer
Laparoscopic adrenalectomy is successful for potentially malignant large tumors - Cardiology
Coronary sinus cannulation is facilitated with a deflectable fiberoptic catheter - Cardiology
ET-1 plasma levels predict angiographic no-reflow after percutaneous coronary intervention - Cardiology
Morphine improves recovery of ventricular function after cardiopulmonary bypass - Orthopedics
Hemiarthroplasty prosthesis survivorship and clinical outcome of 500 patients is evaluated - Acoustic Neuroma
Acoustic neuroma growth patterns analyzed - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
